Queen's Medical Center

This study tested whether the drug tocilizumab could help hospitalized adults with severe COVID-19 pneumonia. Tocilizumab is designed to calm an overactive immune response, which can cause severe lung damage. The trial compared the drug against a placebo to see if it improved pat…

This study aimed to see if adding the drug hydroxychloroquine to standard hospital care helped adults with COVID-19 get better faster. It compared patients who received the drug for five days to those who received only usual care. The trial was stopped early after enrolling only …